Class III · Lower riskActive recall
Diclofenac Sodium
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberBatch XHBG; Exp. 08/31/2027
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed PH Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byDPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215
| Brand name | DICLOFENAC SODIUM |
| Generic name | DICLOFENAC SODIUM |
| Active ingredient(s) | DICLOFENAC SODIUM |
| Distributed by / for | Cipla USA, Inc. |
| NDC | 76282-103-39 |
Show the full FDA record
| Full product label | Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 |
| Recalling firm | Cipla USA, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 92,376 tubes |
| Recall initiated | 2025-12-22 |
| Report date | 2026-01-28 |
| Recall completed | — |
| Recall number | D-0291-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.